Mostrando 10 resultados de: 22
Publisher
Clinical Rheumatology(6)
Journal of Clinical Rheumatology(3)
Autoimmunity Reviews(2)
Clinical Reviews in Allergy and Immunology(2)
Annals of the Rheumatic Diseases(1)
Área temáticas
Enfermedades(15)
Farmacología y terapéutica(11)
Medicina y salud(10)
Ginecología, obstetricia, pediatría, geriatría(2)
Problemas sociales y servicios a grupos(2)
Área de conocimiento
Medicina interna(9)
Inmunología(4)
Obstetricia(3)
Medicamento(2)
Cuidado de la salud(1)
A Consensus Position Paper from REAL-PANLAR Group about the Methodological Approach for the Accreditation Process of Centers of Excellence in Rheumatoid Arthritis in Latin America
ArticleAbstract: Background By 2015, the World Health Organization reported that 1% of the world population sufferedPalabras claves:accbkp_reditation, Latin America, quality of health care, Rheumatoid Arthritis, standard of careAutores:Caballero-Uribe C.V., Cardiel M.H., Castro-Moreno C., Claudio M. Galarza-Maldonado, Diana Carolina Buitrago-García, Massardo L., Pineda-Villaseñor C., Santos-Moreno P., Soriano E.R., Villarreal L.Fuentes:scopusClinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
ArticleAbstract: Objectives: To identify baseline predictors of remission and low disease activity (LDA) in early rhePalabras claves:Early RA outcomes, Early RA remission, Early RA response pbkp_redictors, Latin America early RAAutores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Loreto M., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusCorrection to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort (Clinical Rheumatology, (2019), 38, 10, (2737-2746), 10.1007/s10067-019-04618-x)
OtherAbstract: The original version of this article, unfortunately, contained an error. The first and family name oPalabras claves:Autores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Massardo L., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusCorrection to: PANLAR consensus statement on biosimilars (Clinical Rheumatology, (2019), 38, 5, (1485-1496), 10.1007/s10067-019-04496-3)
OtherAbstract: The two co-authors of the mentioned above article were incorrect. The correct are authors should havPalabras claves:Autores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Beltrán P.A., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Díaz-Coto J.F., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusEarly rheumatoid arthritis in Latin America: Low socioeconomic status related to high disease activity at baseline
ArticleAbstract: Objective To determine the influence of socioeconomic factors on disease activity in a Latin AmericaPalabras claves:Autores:Acevedo-Vásquez E.M., Achurra-Castillo A.F., Caballero-Uribe C.V., Cardiel M.H., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Furst D.E., Guibert-Toledano Z.M., Hernández J.A., Laurindo I.M., Lino-Pérez L., Massardo L., Montufar R.A., Mota L.M.H., Padilla O., Pineda-Villaseñor C., Pons-Estel B.A., Ramírez L.A., Sacnun M.P., Soriano E.R., Wojdyla D.Fuentes:scopusDiagnosis and classification of rheumatoid arthritis
ArticleAbstract: Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease of unclear etiology that is manPalabras claves:Anti-cyclic citrullinated peptide (anti-CCP), Classification criteria, Rheumatoid Arthritis, Rheumatoid factorAutores:Claudio M. Galarza-Maldonado, Esteban Ortiz-Prado, Kourilovitch M.R.Fuentes:scopusFirst Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
ArticleAbstract: Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a sigPalabras claves:lupus nephritis, systemic lupus erythematosus, TreatmentAutores:Acevedo-Vásquez E.M., Acosta Colman M.I., Alarcón G.S., Alba Moreyra P.B., Alvarellos A.J., Amezcua-Guerra L.M., Amigo M.C., Appenzeller S., Aquino A.M., Arturi V., Babini A.M., Barile-Fabris L.A., Berbotto G.A., Betancur G.V., Bonfá E.S.D.D.O., Borba E.F., Brenol J.C.T., Burgos P.I., Cairoli E., Cardiel M.H., Cardoso Linhares F.A., Catoggio L.J., Cavalcanti A., Cavalcanti F.S., Chacón-DÍaz R., Cieza J., Claudio M. Galarza-Maldonado, Collado M.V., Conti S.M., Costallat L.T.L., Criniti J.M., Da Silva N.A., Danza A., Dos Reis Neto E.T., Drenkard C., Duarte M., Eraso Garnica R.M., Espada G., Fragoso-Loyo H.E., Fuentes-Silva Y.J., Gamboa-Cárdenas R.V., García de la Torre I., García M.A., García Valladares I., Gerling C., Gervasoni V.L., Gobbi C.A., Gómez-Martín D., Gómez-Puerta J.A., González Naranjo L.A., González-Bello Y.C., Gordon S., Guibert-Toledano M., Haye Salinas M.J., Herrera Uribe S., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Llanos C., Massardo L., Molina J.F., Montandon De Oliveira E Silva A.C., Monticielo O.A., Montúfar Guardado R.A., Mora-Trujillo C.S., Muñoz-Louis R., Neira O., Orozco M.C., Pera M.A., Pineda-Villaseñor C., Pons-Estel B.A., Pons-Estel G.J., Popoff F., Portela Hernández M., Quintana R.M., Retamozo S., Reyes G.L., Robaina Sevrini R., Rosario V., Sarano J., Sato E.I., Sattler M.E., Saurit V., Savio V., Scherbarth H.R., Scolnik M., Seguro L.P.C., Silva C.A., Silveira L.H., Soriano E.R., Ugarte-Gil M.F., Ugolini-Lopes M.R., Vargas Peña A., Vásquez G., Xavier R.M.Fuentes:scopusInfections and the antiphospholipid syndrome
ReviewAbstract: Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic predispositPalabras claves:Anticardiolipin, Antiphospholipid, infection, ThrombosisAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., Mendoza-Pinto C.Fuentes:scopusIs Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
ArticleAbstract: Purpose: Tofacitinib is recommended for treatment of rheumatoid arthritis (RA) in patients with modePalabras claves:biologics, Rheumatoid Arthritis, tofacitinib, TreatmentAutores:Claudio M. Galarza-Maldonado, Ibata L., Martinez S., Rivero M., Rodríguez-Florido F., Rojas-Villarraga A., Santos-Moreno P., Villarreal L.Fuentes:scopusThe HELLP syndrome, antiphospholipid antibodies, and syndromes
OtherAbstract:Palabras claves:Autores:Asherson R., Claudio M. Galarza-Maldonado, Sanin-Blair J.Fuentes:scopus